We are a clinical stage development and licensing biotechnology company focused on leveraging our
Pfenex Expression Technology™ platform to develop and improve protein therapies for unmet patient needs. Through the use of our state of the art production platform, Pfenex Expression Technology®, we cost-effectively develop and improve high value protein based therapeutics and vaccines, enabling broad access to people who req...
We are a clinical stage development and licensing biotechnology company focused on leveraging our
Pfenex Expression Technology™ platform to develop and improve protein therapies for unmet patient needs. Through the use of our state of the art production platform, Pfenex Expression Technology®, we cost-effectively develop and improve high value protein based therapeutics and vaccines, enabling broad access to people who require them. Pfenex Inc. existed as a privately held biotechnology company from 2009 until our initial public offering in 2015.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.